S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KNSA Kiniksa Pharmaceuticals Ltd

19.40

0.68 (3.63%)

After Hours

Last Updated: 07:30:00

Delayed by 15 minutes

Kiniksa Pharmaceuticals EPS misses by $0.18

To read the full story on Seeking Alpha, click here.

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals Ltd News

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Tuesday 23 April 2024 (1 week ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

More Kiniksa Pharmaceuticals Ltd News Articles

Australian SE All Ordina...

Commonwealth Bank Of Aus...

Sterling vs AUD

Gold vs US Dollar

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions